Department of Human Development and Family Sciences, University of Connecticut, 348 Mansfield Road, U-1058, Storrs, CT, 06269-1058, USA.
UConn Health, Farmington, CT, USA.
Support Care Cancer. 2021 May;29(5):2385-2394. doi: 10.1007/s00520-020-05741-1. Epub 2020 Sep 12.
Breast cancer is the most common non-cutaneous cancer in women with an estimated 268,600 new cases diagnosed in 2019, joining the over 3 million women living with the disease. To reduce cancer recurrence, postmenopausal women (highest incidence and prevalence of breast cancer) who test positive for hormone receptors in their tumors are candidates for adjuvant endocrine therapy (i.e., aromatase inhibitors [AIs]). Despite the benefits of AIs in the treatment for breast cancer, many women remain at risk for complications, including osteoporosis and fractures, all of which can adversely affect health-related quality of life (HRQoL). Increased attention is being paid to the role physical activity (PA) may have in improving health outcomes in survivors of breast cancer, but few studies focus on postmenopausal women. We sought to examine (1) the percentage of women in our sample meeting (or not meeting) the American College of Sports Medicine (ACSM) PA recommendations, (2) the relationship between AI use and three types of PA (leisure time, strength training, and walking), and (3) the relationship between PA and HRQoL by AI use, controlling for covariates.
Postmenopausal women with breast cancer (n = 170), ages 50-95 years (M = 68.7), diagnosed with stage 1-3 disease, 45% on AIs, were recruited. Demographic, HRQoL, and PA data were collected via patient self-report, while clinical data (AI use) were abstracted from patient medical records. To address study aims, we utilized descriptive statistics, chi-square analyses, and multiple linear regressions, respectively.
Half of the sample met the ACSM recommendations for total leisure-time PA (vigorous and moderate intensity combined), and 65.3% (n = 111) weekly walking. With regard to strength training, 36.5% of the women met these ACSM recommendations. Generally, there were positive relationships between AI use and most HRQoL domains. There were no statistically significant relationships between PA (meeting recommendations or not) and HRQoL by AI use.
The proportion of women meeting guidelines for walking activity was encouraging. It is imperative that healthcare professionals providing care to breast cancer survivors follow up regarding symptoms, side effects, and physical activity in tandem to fully understand their relationship on an individual level.
乳腺癌是女性中最常见的非皮肤癌,估计 2019 年有 268600 例新发病例,加上 300 多万名患有该病的女性,这一数字还在不断增加。为了降低癌症复发的风险,肿瘤激素受体检测呈阳性的绝经后妇女(乳腺癌发病率和患病率最高)是辅助内分泌治疗(即芳香化酶抑制剂[AI])的候选者。尽管 AI 在乳腺癌治疗中具有益处,但许多女性仍面临并发症的风险,包括骨质疏松症和骨折,所有这些都会对健康相关生活质量(HRQoL)产生不利影响。人们越来越关注体力活动(PA)在改善乳腺癌幸存者健康结果方面可能发挥的作用,但很少有研究关注绝经后妇女。我们旨在研究:(1)我们样本中符合(或不符合)美国运动医学学院(ACSM)PA 推荐的女性比例;(2)AI 使用与三种类型的 PA(休闲时间、力量训练和步行)之间的关系;(3)控制协变量后,PA 与 AI 使用之间的 HRQoL 关系。
我们招募了 170 名年龄在 50-95 岁(平均年龄 68.7 岁)、患有 1-3 期疾病、45%正在使用 AI 的绝经后乳腺癌女性。通过患者自我报告收集人口统计学、HRQoL 和 PA 数据,而 AI 使用的临床数据(AI 使用)则从患者病历中提取。为了实现研究目的,我们分别利用描述性统计、卡方分析和多元线性回归进行分析。
一半的样本符合 ACSM 推荐的总休闲时间 PA(剧烈和中度强度相结合)标准,65.3%(n=111)每周步行。关于力量训练,36.5%的女性符合 ACSM 的这些建议。一般来说,AI 使用与大多数 HRQoL 领域呈正相关。PA(符合建议或不符合建议)与 AI 使用之间没有统计学上显著的关系。
符合步行活动指南的女性比例令人鼓舞。为了充分了解他们在个人层面上的关系,提供乳腺癌幸存者护理的医疗保健专业人员在关注症状、副作用和体力活动方面进行随访至关重要。